Split History
ETFs Holding BOTA »    BOTA Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biota Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat infections. Co. has four product candidates which include vapendavir (BTA798), an oral treatment for human rhinovirus (HRV) infections in moderate-to-severe asthmatics; BTA074, a Phase 2 topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor in Phase 1 development for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment in Phase 2 development for influenza A and B infections. According to our BOTA split history records, BOTA has had 1 split.
BOTA split history picture
BOTA (BOTA) has 1 split in our BOTA split history database. The split for BOTA took place on November 09, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of BOTA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.

When a company such as BOTA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the BOTA split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BOTA shares, starting with a $10,000 purchase of BOTA, presented on a split-history-adjusted basis factoring in the complete BOTA split history. BOTA split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 07/26/2007
End date: 04/12/2016
Start price/share: $25.74
End price/share: $1.55
Starting shares: 388.50
Ending shares: 492.98
Dividends reinvested/share: $1.11
Total return: -92.36%
Average Annual Total Return: -25.54%
Starting investment: $10,000.00
Ending investment: $764.01
Years: 8.72
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/26/2007
End date: 04/12/2016
Start price/share: $25.74
End price/share: $1.55
Dividends collected/share: $1.11
Total return: -89.67%
Average Annual Total Return: -22.92%
Starting investment: $10,000.00
Ending investment: $1,032.93
Years: 8.72
Date Ratio
11/09/20121 for 6
BOTA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BRLI Split History
BSPM Split History
BSTC Split History
BSX Split History
BTX Split History
CAH Split History
CALA Split History
CAPR Split History
CASC Split History
CBIO Split History

Bridgeline Digital, Inc. (BLIN)
SUPERVALU INC. (SVU)
DryShips Inc. (DRYS)
Peregrine Pharmaceuticals, Inc. (PPHM)
Diana Containerships Inc. (DCIX)
DryShips Inc. (DRYS)
Marten Transport, Ltd. (MRTN)
Arena Pharmaceuticals, Inc. (ARNA)
Cobalt International Energy, Inc. (CIE)
CEL-SCI Corporation (CVM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BOTA Insider Buying

BOTA Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.